Skip to main content
Clinical Trials/ACTRN12618001422213
ACTRN12618001422213
Recruiting
未知

Exercise rehabilitation for cancer survivors with chemotherapy-induced peripheral neuropathy: Impact and mechanisms

Professor David Goldstein0 sites96 target enrollmentAugust 27, 2018

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Professor David Goldstein
Enrollment
96
Status
Recruiting
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 27, 2018
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Professor David Goldstein

Eligibility Criteria

Inclusion Criteria

  • 1\.Grade 2 or 3 chemotherapy\-induced peripheral neuropathy (symptoms affecting function)
  • 2\.At least 3 months post\-neurotoxic cancer treatment
  • 3\.Previously treated with cancer treatments for which neuropathy is a known side effect
  • 4\.Greater than 18 years of age
  • 5\.Able to provide written informed consent
  • 6\.Cleared by a physician to participate in a structured exercise program

Exclusion Criteria

  • ECOG performance status \>/\= 2

Outcomes

Primary Outcomes

Not specified

Similar Trials